ADAR1 Capital Management reports $117,700 InMed Pharma common share purchase

PUBT · 1d ago
ADAR1 Capital Management reports $117,700 InMed Pharma common share purchase
  • ADAR1 Capital Management lifted its indirect stake in InMed Pharmaceuticals to 892,101 common shares through open-market purchases.
  • Daniel Schneeberger, manager, was listed as an indirect beneficial owner through funds managed by ADAR1.
  • Purchases were reported at weighted-average prices around $1.29 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000021), on September 16, 2026, and is solely responsible for the information contained therein.